Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Tutt

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Journal of Immunological Methods|February 27, 2001
CD40 ligation for immunotherapy of solid tumoursS M Todryk, A L Tutt, M H Green, et al.
Blood|June 24, 2004
A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cellsMark S Cragg, Mike B Bayne, Alison L Tutt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(+) T cellsDrew J Roberts, Nathan A Franklin, Lara M Kingeter, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1992
Initial experience in treating human lymphoma with a combination of bispecific antibody and saporinM A Bonardi, A Bell, R R French, et al.
European Journal of Immunology|July 25, 2008
CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responsesFernanda V V Castro, Alison L Tutt, Ann L White, et al.
Cancer Research|September 23, 2003
CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane raftsH T Claude Chan, David Hughes, Ruth R French, et al.
Scandinavian Journal of Rheumatology|November 28, 2000
Rheumatoid arthritis T cells produce Th1 cytokines in response to stimulation with a novel trispecific antibody directed against CD2, CD3, and CD28W M Wong, S A Vakis, K R Ayre, et al.
Blood|February 22, 2007
Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulationRuth R French, Vadim Y Taraban, Graham R Crowther, et al.
European Journal of Immunology|January 9, 2003
Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responsesVadim Y Taraban, Tania F Rowley, Lyn O'Brien, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectorsA L Tutt, R R French, T M Illidge, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of Immunological Methods|February 27, 2001
CD40 ligation for immunotherapy of solid tumoursS M Todryk, A L Tutt, M H Green, et al.
Blood|June 24, 2004
A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cellsMark S Cragg, Mike B Bayne, Alison L Tutt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(+) T cellsDrew J Roberts, Nathan A Franklin, Lara M Kingeter, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1992
Initial experience in treating human lymphoma with a combination of bispecific antibody and saporinM A Bonardi, A Bell, R R French, et al.
European Journal of Immunology|July 25, 2008
CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responsesFernanda V V Castro, Alison L Tutt, Ann L White, et al.
Cancer Research|September 23, 2003
CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane raftsH T Claude Chan, David Hughes, Ruth R French, et al.
Scandinavian Journal of Rheumatology|November 28, 2000
Rheumatoid arthritis T cells produce Th1 cytokines in response to stimulation with a novel trispecific antibody directed against CD2, CD3, and CD28W M Wong, S A Vakis, K R Ayre, et al.
Blood|February 22, 2007
Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulationRuth R French, Vadim Y Taraban, Graham R Crowther, et al.
European Journal of Immunology|January 9, 2003
Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responsesVadim Y Taraban, Tania F Rowley, Lyn O'Brien, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectorsA L Tutt, R R French, T M Illidge, et al.
Pageof 6